Colgate-Palmolive FY2025 Q1 Financial Report: Net Income $690M Up 0.9%

Executive Summary

In the first quarter of fiscal year 2025, Colgate-Palmolive reported a net income of $690 million, representing a 0.9% increase compared to $683 million in the same period last year. Revenue declined slightly by 3.0%, from $5.065 billion to $4.911 billion, primarily due to market dynamics and currency fluctuations. The company’s gross profit remained stable at $2.987 billion, with a gross margin of approximately 60.8%. Operating income increased modestly by 2.7%, driven by cost management and efficiency initiatives. The balance sheet shows a solid liquidity position with cash and cash equivalents totaling $1.112 billion, and total assets reaching $16.647 billion. Cash flows from operating activities were $600 million, reflecting strong core business performance. The company maintains a disciplined approach to capital expenditures and dividends, with $124 million spent on CapEx and dividends paid of $406 million during the quarter. Overall, Colgate-Palmolive demonstrates resilience amid challenging market conditions, with stable profitability and healthy liquidity, supporting a positive long-term outlook.

Key Metrics

Management Discussion and Analysis

Colgate-Palmolive’s Q1 FY2025 results reflect a resilient core business with stable gross margins and a slight increase in net income. The revenue decline of 3.0% is attributable to currency headwinds and market softness in certain regions. Cost control measures and operational efficiencies contributed to a modest increase in operating income. The company’s strong cash flow generation supports ongoing investments, debt management, and shareholder returns. Despite macroeconomic challenges, the company’s diversified global footprint and focus on innovation position it well for sustainable growth.

Income Statement Analysis

Revenue decreased by 3.0%, from $5.065 billion to $4.911 billion, mainly due to adverse currency effects and market conditions. Gross profit remained stable at $2.987 billion, with gross margin holding at approximately 60.8%. Operating income increased by 2.7%, reaching $1.076 billion, supported by lower operating expenses and efficiency initiatives. Net income grew slightly by 0.9%, from $683 million to $690 million, translating into earnings per share of $0.85, up 2.4% YoY. These figures indicate effective cost management and operational resilience amid external pressures.

Balance Sheet Analysis

The company’s total assets increased by 3.8%, from $16.046 billion to $16.647 billion, driven by higher receivables and inventories. Cash and cash equivalents grew by 1.5%, totaling $1.112 billion, providing liquidity flexibility. Total liabilities rose by 2.7%, from $15.502 billion to $15.914 billion, mainly due to increased debt levels. Shareholders’ equity improved to $733 million, reflecting retained earnings growth and favorable currency translation adjustments. The company’s liquidity position remains robust, with a current ratio of approximately 0.85, supported by strong operating cash flows.

Cash Flow Analysis

Net cash provided by operating activities was $600 million, slightly below the prior year’s $681 million, due to working capital changes. Capital expenditures totaled $124 million, focusing on capacity expansion and efficiency upgrades. The company paid dividends of $406 million and repurchased shares worth $284 million, demonstrating commitment to shareholder returns. Financing activities included short-term borrowings and debt repayments, with net debt increasing modestly. Overall, cash flow dynamics support ongoing strategic investments and shareholder distributions.

Ratios & DuPont Analysis

Net profit margin stands at approximately 14.0%, indicating stable profitability. Return on assets (ROA) is around 4.1%, and return on equity (ROE) is approximately 94.2%, driven by high leverage and retained earnings. Asset turnover ratio is about 0.30, reflecting efficient utilization of assets. The equity multiplier is approximately 22.7, highlighting the company’s leveraged capital structure. These ratios suggest a balanced approach to growth and risk management, with a focus on maximizing shareholder value.

Risk Factors

Colgate-Palmolive faces risks from regulatory changes, market competition, currency fluctuations, and supply chain disruptions. Macroeconomic uncertainties and inflationary pressures could impact consumer spending and input costs. Legal contingencies, including product liability and environmental claims, pose ongoing challenges. The company’s global footprint exposes it to geopolitical risks and compliance complexities. Strategic investments in innovation and digital transformation are essential to maintain competitive advantage amid evolving consumer preferences.

Notes & Additional Commentary

Unusual items in the quarter include a $50 million expense related to ERISA litigation, which is expected to be a recurring consideration. The company also recognized restructuring charges of $36 million associated with productivity initiatives concluded in 2024. Currency translation effects impacted the balance sheet and income statement, emphasizing the importance of hedging strategies. No material impairments or asset write-downs were recorded during this period.

Investment Implications

Colgate-Palmolive’s stable earnings, strong cash flow, and disciplined capital allocation support a positive long-term outlook. Short-term opportunities include leveraging innovation in core categories and expanding digital marketing. Risks from macroeconomic volatility and legal contingencies warrant cautious monitoring. The company’s resilient business model and focus on operational efficiency position it well to navigate external challenges and deliver sustainable shareholder value over the coming years.